GLP-1 inhibitors, like tirzepatide, show promise in reducing AHI in OSA patients with obesity, as demonstrated in the SURMOUNT trials. Experts highlight the importance of integrating GLP-1s with diet ...
Sleep apnea? What’s that? It may be a new medical term and condition for you; you may not even know you are experiencing it.
Progressive discontinuation of antihypertensive medications did not lower risk for mortality compared with usual care among ...